Temozolomide in Aggressive Pituitary Neuroendocrine Tumors: A Latin American Multicenter Retrospective Cohort (TMZ-LATAM)

NCT07695844 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Pituitary Neoplasms

Interventions

DRUG: temozolamide
DRUG: Temozolamide

Sponsor

University of Sao Paulo General Hospital